Hepatic Function SPECT Testing Before and During Radiotherapy Can Help in Treatment Planning for Liver Cancer Patients

March 4, 2013

Hepatic Function SPECT Testing Before and During Radiotherapy Can Help in Treatment Planning for Liver Cancer Patients

Monitoring the hepatic function of unresectable liver cancer patients evaluated by 99mTc-labeled iminodiacetic acid (HIDA) used with single-photon emission computed tomography (SPECT) imaging before and during radiation therapy provides critical data that could guide more customized treatment plans and reduce risks of liver injury, according to recent research.